Harrow, Inc. balance sheet
At the end of fiscal 2025, Harrow, Inc. had total assets of $399m, total liabilities of $347m and shareholders' equity of $52.4m. It held $72.9m in cash against $250m of debt.
Balance sheet
| Fiscal year | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 16 | 8 | 3 | 9 | 4 | 7 | 5 | 4 | 42 | 96 | 74 | 47 | 73 | 84 |
| Receivables | — | 0 | 1 | 3 | 2 | 2 | 2 | 3 | 4 | 6 | 36 | 116 | 111 | 119 |
| Inventory | — | 0 | 1 | 2 | 2 | 2 | 3 | 4 | 4 | 7 | 11 | 11 | 14 | 17 |
| Total current assets | 16 | 9 | 6 | 15 | 9 | 33 | 36 | 41 | 61 | 118 | 139 | 190 | 212 | 229 |
| Goodwill | — | 0 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 16 | 10 | 14 | 27 | 24 | 49 | 59 | 57 | 98 | 157 | 312 | 389 | 399 | 417 |
| Accounts payable | — | — | — | — | — | — | — | — | — | — | — | 39 | 35 | 26 |
| Deferred revenue (current) | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Total current liabilities | 1 | 2 | 5 | 10 | 6 | 12 | 12 | 11 | 10 | 19 | 49 | 91 | 96 | 102 |
| Short-term debt | — | — | — | — | — | 1 | — | — | — | — | — | — | — | — |
| Long-term debt | — | — | 8 | 8 | 23 | 23 | 12 | 20 | 103 | 152 | 247 | 263 | 250 | 292 |
| Total debt | 0 | 0 | 8 | 12 | 14 | 15 | 14 | 24 | 75 | 110 | 195 | 227 | 250 | 300 |
| Total liabilities | 1 | 2 | 16 | 21 | 21 | 25 | 32 | 31 | 87 | 130 | 242 | 320 | 347 | 402 |
| Shareholders' equity | 15 | 8 | −1 | 6 | 3 | 25 | 28 | 27 | 11 | 28 | 71 | 70 | 52 | 15 |
| Shares outstanding | 9m | 9m | 10m | — | 21m | 24m | 26m | 26m | 27m | 30m | 35m | 36m | 37m | 37m |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 54 | 116 | 77 | 79 | 78 | 111 | 101 | 119 |
| Inventory | 10 | 11 | 11 | 12 | 13 | 14 | 16 | 17 |
| Total current assets | 147 | 190 | 170 | 155 | 178 | 212 | 226 | 229 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total assets | 352 | 389 | 364 | 345 | 363 | 399 | 420 | 417 |
| Accounts payable | — | 39 | 37 | 23 | 19 | 35 | 26 | 26 |
| Deferred revenue (current) | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Total current liabilities | 95 | 91 | 187 | 249 | 65 | 96 | 91 | 102 |
| Long-term debt | 231 | 263 | 257 | 251 | 347 | 250 | 300 | 292 |
| Total debt | 231 | 263 | 257 | 251 | 347 | 250 | 300 | 292 |
| Total liabilities | 294 | 320 | 308 | 296 | 316 | 347 | 391 | 402 |
| Shareholders' equity | 58 | 70 | 56 | 50 | 47 | 52 | 29 | 15 |
| Shares outstanding | 36m | 36m | 36m | 37m | 37m | 37m | 37m | 37m |
Compare with peers
- Evolus, Inc. balance sheet
- Aurora Cannabis Inc balance sheet
- Vanda Pharmaceuticals Inc. balance sheet
- Xeris Biopharma Holdings, Inc. balance sheet
- Ironwood Pharmaceuticals Inc balance sheet
Head to head: EOLS vs HROWACB vs HROWHROW vs VNDAHROW vs XERS
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies